mavacamten
mavacamten is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand name including CAMZYOS. Available dosage forms: capsule, capsule, gelatin coated.
Drug Details
- Generic Name
- mavacamten
- Brand Names
- CAMZYOS
- Application Number
- NDA214998
- Sponsor
- Patheon, Inc.
- NDC Codes
- 12
- Dosage Forms
- CAPSULE, CAPSULE, GELATIN COATED
- Routes
- ORAL
- Active Ingredients
- MAVACAMTEN
Indications and Usage
1 INDICATIONS AND USAGE CAMZYOS ® is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. CAMZYOS is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. ( 1 )